Skip to main content

Month: February 2021

Baltic Horizon will hold an Investor Conference Webinar to introduce the results for Q4 2020 report

Baltic Horizon Fund invites unitholders, investors, analysts and other stakeholders to join its investor conference webinar, scheduled on 22 February 2021 at 13:00 PM (CET) or 14:00 PM (EET).The webinar will be hosted by Tarmo Karotam, the Fund Manager of Baltic Horizon Fund. Q&A session will follow after the presentation. Due to limited webinar time, we encourage participants to send their questions no later than one day before the webinar to tarmo.karotam@nh-cap.com.To join the webinar, please register via the following link:  https://attendee.gotowebinar.com/register/7102356245784972302You will be provided with the webinar link and instructions how to join successfully. When joining the webinar for the first time, you will be asked to download the plug-in which will take only few seconds. In case plug-in can’t be downloaded,...

Continue reading

Baltic Horizon will hold an Investor Conference Webinar to introduce the results for Q4 2020 report

Baltic Horizon Fund invites unitholders, investors, analysts and other stakeholders to join its investor conference webinar, scheduled on 22 February 2021 at 13:00 PM (CET) or 14:00 PM (EET).The webinar will be hosted by Tarmo Karotam, the Fund Manager of Baltic Horizon Fund. Q&A session will follow after the presentation. Due to limited webinar time, we encourage participants to send their questions no later than one day before the webinar to tarmo.karotam@nh-cap.com.To join the webinar, please register via the following link:  https://attendee.gotowebinar.com/register/7102356245784972302You will be provided with the webinar link and instructions how to join successfully. When joining the webinar for the first time, you will be asked to download the plug-in which will take only few seconds. In case plug-in can’t be downloaded,...

Continue reading

Baltic Horizon korraldab 2020. aasta neljanda kvartali majandustulemuste tutvustamiseks investorite veebiseminari

Baltic Horizon Fund kutsub osakuomanikke, investoreid, analüütikuid ja teisi huvilisi osalema oma investorite veebiseminaril 22. veebruaril 2021.a. kell 13:00 (CET) / 14:00 (EET).Veebiseminari juhib Baltic Horizon Fund fondijuht Tarmo Karotam. Presentatsioonile järgneb küsimustevoor. Piiratud aja tõttu soovitame osalejatel saata oma küsimused hiljemalt üks päev varem, enne veebiseminari toimumist e-mailile tarmo.karotam@nh-cap.com.Veebiseminaril osalemiseks palume teil registreerida järgneva lingi kaudu:   https://attendee.gotowebinar.com/register/7102356245784972302Teile saadetakse link ning juhised veebiseminariga liitumiseks. Kui osalete veebiseminaril esimest korda, palutakse teil alla laadida vajalik rakendus, mis võtab vaid mõned sekundid. Juhul kui rakenduse allalaadimine ei õnnestu, avaneb automaatselt veebibrauser, mille kaudu...

Continue reading

Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

New agreement brings total supply to the European Union to 500 million doses, with delivery expected by the end of 2021European Commission has the option to request an additional 100 million dosesNEW YORK and MAINZ, GERMANY, February 17, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the European Commission (EC) to supply an additional 200 million doses of COMIRNATY®, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states. The EC has the option to request supply of an additional 100 million doses.This new agreement is in addition to the 300 million doses that have already been committed to the EU through 2021 under the first supply agreement signed last year. The additional 200 million doses are expected to be delivered in 2021, with an estimated 75...

Continue reading

Pfizer und BioNTech beliefern die Europäische Union mit 200 Millionen weiteren COMIRNATY®-Impfstoffdosen

Mit der neuen Vereinbarung liegt die Gesamtbestellmenge bei 500 Millionen Dosen; Lieferung bis Ende 2021 erwartetDie Europäische Kommission hat die Option, weitere 100 Millionen Dosen zu bestellenNEW YORK, USA und MAINZ, Deutschland, 17. Februar 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX) gaben heute eine Vereinbarung mit der Europäischen Kommission (EK) über die Lieferung weiterer 200 Millionen Dosen ihres COVID-19-Impfstoffs COMIRNATY® an die 27 EU-Mitgliedsstaaten bekannt. Die EK hat außerdem die Option, weitere 100 Millionen Dosen zu bestellen.Diese neue Vereinbarung ergänzt den im vergangenen Jahr geschlossenen Vertrag über 300 Millionen Dosen, die der EU bereits für das Jahr 2021 zugesichert wurden. Die zusätzlichen 200 Millionen Impfstoffdosen werden voraussichtlich in 2021 ausgeliefert, wobei...

Continue reading

Company announcement no 2/2021 January 2021 Sales price

January 2021 Sales priceGroup sales prices development as followsQ1           2017       1,24 EUR/kg live weight (Jan 1,23 EUR – Feb 1,24 EUR – Marts 1,26 EUR)Q2           2017       1,41 EUR/kg live weight (Apr 1,43 EUR – May 1,41 EUR – June 1,39 EUR)Q3           2017       1,30 EUR/kg live weight (July 1,32 EUR – Aug 1,30 EUR – Sept 1,29 EUR)Q4           2017       1,13 EUR/kg live weight (Oct 1,17 EUR – Nov 1,12 EUR – Dec 1,11 EUR)Q1           2018       1,09 EUR/kg live weight (Jan 1,07 EUR – Feb 1,08 EUR – Marts 1,12 EUR)Q2           2018       1,17 EUR/kg live weight (April 1,18 EUR – May 1,15 EUR – June 1,18 EUR)Q3           2018       1,19 EUR/kg live weight (July 1,19 EUR, August 1,18 EUR, September 1,19)Q4           2018       1,10 EUR/kg live weight (Oct 1,11 EUR – Nov 1,12 EUR – Dec 1,07 EUR)Q1           2019       1,05 EUR/kg...

Continue reading

Norsk Hydro: Close Associate of Primary insider purchases ADRs

Cynthia Kukielski Spousal Trust, a Close Associate of Director of the Board of Directors in Norsk Hydro, Peter Kukielski, has on February 16, 2021 at 19:49 CET purchased 1,000 American Depositary Receipts (ADRs) in Hydro at USD 5.01 per ADR and 2,000 ADRs in Hydro at USD 5.02 per ADR.New holding is 3,000 ADRs.The ADRs were purchased on OTCQX.Investor contact:Line HaugetraaHead of Investor Relations+4741406376line.haugetraa@hydro.comThis information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.